BC46 The Board considered whether a subsequent increase in fair value less costs to sell should be recognised to the extent that it reversed previous impairments. SFAS 144 requires the recognition of a subsequent increase in fair value less costs to sell, but not in excess of the cumulative loss previously recognised for a write-down to fair value less costs to sell. The Board decided that, under IFRSs, a gain should be recognised to the extent that it reverses any impairment of the asset, either in accordance with the IFRS or previously in accordance with IAS 36. Recognising a gain for the reversal of an impairment that occurred before the classification of the asset as held for sale is consistent with the requirement in IAS 36 to recognise reversals of impairment.